Search

everythinglearnresearchcommunity

for

Search:↓

Hair from people with seborrheic dermatitis is thicker scaled, more damaged, and thinner than healthy hair, and atomic force microscopy can help monitor the condition.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

A rare scalp condition mainly in older women can be treated with various alternatives to steroids, which may have fewer side effects.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Two elderly men developed scalp inflammation after using a gel for skin lesions, which healed with treatment except for some permanent hair loss.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Si Jun Zi Tang may slow aging by affecting specific cell signaling pathways.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

The document says that there are treatments for hair and nail diseases.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.